Clinical trial NCT01409759: Perforator Based Interposition Plasty
Official title: Perforator Based Interposition Flaps for Sustainable Release of Burn Scar Contracture: a Reliable, Simple and Versatile Technique. A Randomised Controlled Trial.
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: PHASE2
Conditions: Burn Scar Contraction
Keywords: Perforators
Interposition plasty
Contracture release
Lead sponsor: Association of Dutch Burn Centres
Sponsor class: OTHER
First posted: 2011-08-04
Enrollment: 50
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Objective: to evaluate the perforator based interposition plasty in comparison to the standard technique (full thickness graft) for scar contracture releases.

Study design: A randomised controlled multicentre intervention study.

Study population: Patients, aged 18 years and older, who require surgery for release of a scar contracture, are eligible for this study. In total 50 patients will be recruited with a follow-up of 3 months post-operatively.

Intervention: A release of the contracture will be performed in combination with òr the standard technique (full thickness graft) òr the perforator based interposition plasty.

Main study parameters/endpoints: the main study parameter is the amount of contraction of the flap/graft after three months.

Detailed description: Rationale:

Scar contracture remains a considerable problem for the burned patient. The standard method of treatment is contracture release in combination with the application of a full or split thickness graft to close the defect. Unfortunately, the effectiveness of skin grafts is limited by scar contraction, which often necessitates additional reconstructions. Moreover, parts of the skin graft may be lost due to poor revascularisation or infection.

Since the discovery of perforator vessels, many types of new flaps can be harvested as long as it incorporates a perforator bundle (artery and vein). This flap design based on perforator vessels and local available skin, should lead to an increased flap survival and superior functional outcome. Based on this concept we developed and explored the possibility of an algorithm for treatment by means of a pilot study performed on 22 patients with a scar contracture. Results show a survival of all flaps of 100% and an expansion of the surface area by 16% after a follow up of at least 3 months. However the implications of the use of perforator based flaps for burn surgery by means of a RCT has yet to be determined.

Primary objective:

Is interpositioned skin of superior quality, as represented by less contraction with the use of the perforator based interposition flaps, compared to the gold standard (full thickness grafts), after 3 months, as measured by transparent sheet planimetry?

Secondary objectives:

* Survival of the flap/graft: i.e. measured by the amount of necrosis
* The quality of the scar: elasticity, colour, subjective scar evaluation

Inclusion criteria are:

* Indication for release of burn scar contracture
* Sufficient tissue for a perforator- based interposition flap (preferably normal skin)
* Able to give informed consent

Exclusion criteria are:

* Age \< 18 years
* Location: scars on the face and scalp
* Smoking (however, the patient is eligible if smoking is quit \> 3 weeks before the operation)
* Psychiatric disorders (if a loss to follow-up is anticipated)
* Language barrier

Eligibility criteria: Inclusion Criteria:

* Indication for release of burn scar contracture
* Sufficient tissue for a perforator- based interposition flap (preferably normal skin)
* Able to give informed consent

Exclusion Criteria:

* Age \< 18 years
* Location: scars on the face and scalp
* Smoking (however, the patient is eligible if smoking is quit \> 3 weeks before the operation)
* Psychiatric disorders (if a loss to follow-up is anticipated)
* Language barrier

Primary outcomes:
measure: Expansion/contraction of the interpositioned skin after 3 months
timeFrame: 3 months
Secondary outcomes:
Other outcomes:
Locations:
city: Beverwijk
country: Netherlands
facility: Red Cross Hospital
state: Noord-Holland
city: Rotterdam
country: Netherlands
facility: Maastad Hospital
state: Zuid-Holland
city: Groningen
country: Netherlands
facility: Martini Hospital, Burns centre
Study officials:
affiliation: Red Cross Hospital
name: Paul P M Van Zuijlen, Prof
role: PRINCIPAL_INVESTIGATOR
References: